Neuronetics Inc (NASDAQ: STIM) kicked off on Tuesday, up 3.21% from the previous trading day, before settling in for the closing price of $3.43. Over the past 52 weeks, STIM has traded in a range of $0.52-$5.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.71%. While this was happening, its average annual earnings per share was recorded 74.08%. With a float of $36.60 million, this company’s outstanding shares have now reached $65.82 million.
Let’s determine the extent of company efficiency that accounts for 716 employees. In terms of profitability, gross margin is 63.51%, operating margin of -43.29%, and the pretax margin is -53.68%.
Neuronetics Inc (STIM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Neuronetics Inc is 44.39%, while institutional ownership is 25.97%. The most recent insider transaction that took place on May 12 ’25, was worth 826,074. In this transaction EVP, CFO and Treasurer of this company sold 193,460 shares at a rate of $4.27, taking the stock ownership to the 416,593 shares. Before that another transaction happened on May 13 ’25, when Company’s EVP, CFO and Treasurer sold 6,540 for $4.16, making the entire transaction worth $27,206. This insider now owns 410,053 shares in total.
Neuronetics Inc (STIM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.08% per share during the next fiscal year.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Take a look at Neuronetics Inc’s (STIM) current performance indicators. Last quarter, stock had a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Looking closely at Neuronetics Inc (NASDAQ: STIM), its last 5-days average volume was 0.85 million, which is a drop from its year-to-date volume of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 36.44%.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 23.72%, which indicates a significant decrease from 47.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.34% in the past 14 days, which was lower than the 100.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.03, while its 200-day Moving Average is $2.66. However, in the short run, Neuronetics Inc’s stock first resistance to watch stands at $3.62. Second resistance stands at $3.70. The third major resistance level sits at $3.79. If the price goes on to break the first support level at $3.44, it is likely to go to the next support level at $3.35. Now, if the price goes above the second support level, the third support stands at $3.27.
Neuronetics Inc (NASDAQ: STIM) Key Stats
The company with the Market Capitalisation of 233.00 million has total of 65,820K Shares Outstanding. Its annual sales at the moment are 74,890 K in contrast with the sum of -43,710 K annual income. Company’s last quarter sales were recorded 31,980 K and last quarter income was -12,680 K.
